Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Zhou, Caicun, Prof, Wu, Yi-Long, Prof, Chen, Gongyan, Prof, Feng, Jifeng, Prof, Liu, Xiao-Qing, Prof, Wang, Changli, Prof, Zhang, Shucai, Prof, Wang, Jie, Prof, Zhou, Songwen, MD, Ren, Shengxiang, MD, Lu, Shun, Prof, Zhang, Li, Prof, Hu, Chengping, Prof, Hu, Chunhong, Prof, Luo, Yi, Prof, Chen, Lei, Prof, Ye, Ming, Prof, Huang, Jianan, Prof, Zhi, Xiuyi, Prof, Zhang, Yiping, Prof, Xiu, Qingyu, Prof, Ma, Jun, Prof, You, Changxuan, Prof
Published in The lancet oncology (01.08.2011)
Published in The lancet oncology (01.08.2011)
Get full text
Journal Article
Outcomes after multidisciplinary blood management in adult patients undergoing cardiac surgery: a retrospective observational study
Ji, Hongwen, Prof Dr, Li, Zhiyuan, MD, Sun, Hansong, Prof, Li, Lihuan, Prof, Ma, Li, BA, Chen, Lei, Prof MD, Long, Cun, Prof MD, Wang, Wei, Prof, Hu, Shengshou, Prof
Published in The Lancet (British edition) (01.10.2015)
Published in The Lancet (British edition) (01.10.2015)
Get full text
Journal Article